Pulmonary Valve Replacement

Pulmonary valve replacement

Severe Pulmonary Insufficiency on echocardiogram.

Moderately dilated right ventricle with an EDV of 100 mL/m^2 , ESV of 56 mL/m^2 , SV of 72 mL, and Ejection Fraction of 44% on MRI.

none

25 mm bioprosthetic valve

Bicaval cardiopulmonary bypass, Patent was given 15ml/kg of Del Nido cardioplegia solution and kept normothermic throughout the case.

Transthoracic echocardiogram, Cardiac MRI

TOF with PA, S/P Monocuspid Gortex leaflet graft

Risks include: Redo sternotomy, injury to coronary arteries with dissection of the RVOT and compression of coronary with malposition of the prosthetic Pulmonary valve

none

Comprehensive Surgical management of Congenital Heart Disease – Richard Jonas ISBN: 978-1-4441-1215-3

McKenzie, E. D., Khan, M. S., Dietzman, T. W., Guzmán-Pruneda, F. A., Samayoa, A. X., Liou, A., Heinle, J. S., & Fraser, C. D., Jr (2014). Surgical pulmonary valve replacement: a benchmark for outcomes comparisons. The Journal of thoracic and cardiovascular surgery, 148(4), 1450–1453. https://doi.org/10.1016/j.jtcvs.2014.02.060

Tatewaki, H., & Shiose, A. (2018). Pulmonary valve replacement after repaired Tetralogy of Fallot. General thoracic and cardiovascular surgery, 66(9), 509–515. https://doi.org/10.1007/s11748-018-0931-0